eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Subscription
SCImago Journal & Country Rank

vol. 3

Original paper
Effects of absorbed dose of 131I isotope on the effectiveness of ablation of thyroid remnant tissue

Zbigniew Adamczewski
Jacek Makarewicz
Andrzej Lewiński

Arch Med Sci 2007; 3, 2: 136-141
Online publish date: 2007/06/29
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Introduction: The aim of the study was the assesment of effective ablative dose of absorbed 131I radiation, based on dosimetric measurements. Material and methods: The study group comprised one hundred (100) patients in whom papillary thyroid carcinoma (PTC, 54 cases) and follicular thyroid carcinoma (FTC, 46 cases) had been diagnosed. The activities of 131I, administered to those patients, ranged from 1643 MBq (44.4 mCi) to 4033 MBq (109 mCi). The following parameters were determined in the patients before radioiodine therapy: the mass of thyroid remnants [M (g)], iodine uptake [U %], and the effective half-life of radioiodine [EHL (days)]. After obtaining the results of measurements, the dose [D (Gy)] absorbed by thyroid remnants was retrospectively calculated by means of our own modification of the Marinelli formula. Additionally the effect of the analyzed parameters on ablation effectiveness was assessed. Results: In 80 patients (80%) the performed ablation was evaluated as effective. The most effective (91%) was the ablation in the group of patients who received an absorbed dose of 2400 Gy or higher. A correlation was found between the absorbed dose and the effectiveness of ablation (rs=0.23; p<0.05). The effectiveness of ablation was also related to the mass of thyroid remnants, being higher in patients with the mass Ł1.5 γ (91%) than in those with the mass >1.5 γ (68%) (p<0.03). Conclusions: A correlation has been demonstrated between ablation effectiveness and the 131I dose absorbed by thyroid remnants. The highest effectiveness of ablation was obtained after the administration of D ł2400 Gy.

differentiated thyroid carcinoma; radioiodine-131, dosimetry, ablation

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.